Stereotactic Ablative Radiotherapy in... - Advanced Prostate...

Advanced Prostate Cancer

21,284 members26,573 posts

Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study

Maxone73 profile image
4 Replies

"The most common primary malignancy types were prostate (n = 14), colorectal (n = 10), lung (n = 7), and breast cancers (n = 6). The median follow-up was 30 months, ranging from 9 to 79. The 1-, 3-, and 5-year PFS and OS rates were 54.9%, 37.0%, and 37.0% and 98.3%, 84.4%, and 73.8%, respectively, and the median time to first progression was 15 (range, 2-32) months. Twenty-four (40%) patients had no recurrence. In our analysis, primary tumor site was not an independent prognostic factor. "

ascopubs.org/doi/10.1200/GO...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Jewelrylady profile image
Jewelrylady

interesting study, but only 3 prostate cancer patients, and authors note results may be worse with a larger PC population.

Maxone73 profile image
Maxone73 in reply to Jewelrylady

thought they were 14??

Jewelrylady profile image
Jewelrylady in reply to Maxone73

Sorry, it did say 14 patients. Not sure where I got 3, but here is what it said about the 14. Hopefully there are more studies that can validate the 100% survival rate for men with only bone metastasis. Thank you for sharing the article. I found it hopeful.

“In addition, we analyzed the relationship between the primary tumor site and OS/PFS (Figs 2 and 3). There was no correlation observed in a pairwise comparison of all primary tumor sites (the P value was >.05). The smaller number of patients in our cohort might also have influenced this outcome. We have noted some differences in OS in patients with prostate cancer (P = .073), which had a 100% OS rate. We suppose that this is primarily because the prostate cancers in our study had only bone metastases because of early detection of metastases. We assume that if we had more patients with prostate cancer with metastases to other sites, the OS rates would be worse.”

j-o-h-n profile image
j-o-h-n

Title: Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study.

I started whispering this title to my blow up doll and she winked at me. What the hell do you think she means/wants?

Good Luck, Good Health and Good Humor.

j-o-h-n

You may also like...

Stereotactic ablative radiotherapy for new recurrent prostate cancer nodule.

Stereotactic ablative radiotherapy for small local recurrent prostate cancer nodule? And if not...

Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease

Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via PSMA pet scan

in-field failures. ! ! ! ! ! Median bDFS was not affected by prostate-specific antigen (PSA) at...

Heading for Stereotactic Radiotherapy

required for the hospital to locate the cancer they were confident and I had it done on 28th...

Radiotherapy in the Definitive Management of Oligometastatic Prostate Cancer

was 7.4% at 24 months. Median biochemical PFS was 12.9 months, and the median time to next...